Daniel J. Brennan insider trades

Open-market stock purchases and sales by Daniel J. Brennan, Director at Madrigal Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 16, 2014.

Recent trades

DateStockTradeValue
Jun 17, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jun 17, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Feb 25, 2026WAT Waters Corp /de/Bought (not open market)—
Feb 25, 2026WAT Waters Corp /de/Bought (not open market)—
Jan 2, 2026WAT Waters Corp /de/Bought (not open market)—
Jan 2, 2026WAT Waters Corp /de/Bought (not open market)—

Companies traded

  • MDGL Madrigal Pharmaceuticals, Inc: other filings, last Jun 17, 2026
  • WAT Waters Corp /de/: other filings, last Feb 25, 2026
  • BSX Boston Scientific Corp: 28 sales, last Feb 19, 2025
  • NUAN Nuance Communications, Inc: other filings, last Mar 4, 2022

Get free alerts when Daniel J. Brennan files a new trade →